Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00256542
Status:
COMPLETED
Last Update Posted:
2006-09-29
First Post:
2005-11-17
Brief Title:
Study of U101 for Bladder Pain andor Urgency
Sponsor:
Urigen
Organization:
Urigen
Study Overview
Official Title:
A Phase II Multi-Center Randomized Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravesical Alkalinized Lidocaine-Heparin for the Symptoms of Pelvic Pain andor Urgency of Bladder Origin
Status:
COMPLETED
Status Verified Date:
2006-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether intravesical U101 alkalinized lidocaine-heparin treatment reduces the symptoms of pelvic pain andor urgency of bladder origin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None